DDMC-p53 gene therapy with or without cisplatin and microwave ablation

Wolfgang Hohenforst-Schmidt1 II Medical Clinic, Coburg Hospital, University of Wuerzburg, Coburg, Germany

Paul Zarogoulidis2 Pulmonary Department-Oncology Unit, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]

Joshua Stopek3 Covidien, Jersey City, NJ, USA

Thomas Vogl4 Department of Diagnostic and Interventional Radiology, Goethe University of Frankfurt, Frankfurt, Germany

Frank Hübner1 II Medical Clinic, Coburg Hospital, University of Wuerzburg, Coburg, Germany

J Francis Turner5 Division of Interventional Pulmonology, Western Regional Medical Center, Goodyear, AZ;6 Medical Oncology, Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ

Robert Browning7 Pulmonary and Critical Care Medicine, Interventional Pulmonology, National Naval Medical Center, Walter Reed Army Medical Center, Bethesda, MD, USA

Konstantinos Zarogoulidis2 Pulmonary Department-Oncology Unit, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Antonis Drevelegas8 Radiology Department, Interbalkan European Medical Center, Thessaloniki, Greece

Konstantinos Drevelegas8 Radiology Department, Interbalkan European Medical Center, Thessaloniki, Greece

Kaid Darwiche9 Department of interventional Pneumology, Ruhrlandklinik, University Hospital Essen, University of Essen-Duisburg, Essen, Germany

Lutz Freitag9 Department of interventional Pneumology, Ruhrlandklinik, University Hospital Essen, University of Essen-Duisburg, Essen, Germany

Harald Rittger10 Medical Clinic I, ‘Fuerth Hospital, University of Erlangen, Erlangen, Germany

show all